NDatalyze (XCNQ:NDAT) Debt-to-Revenue : 0.00 (As of Nov. 2023)

View and export this data going back to 2019. Start your Free Trial

What is NDatalyze Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

NDatalyze's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2023 was C$0.00 Mil. NDatalyze's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2023 was C$0.00 Mil. NDatalyze's annualized Revenue for the quarter that ended in Nov. 2023 was C$0.15 Mil. NDatalyze's annualized Debt-to-Revenue for the quarter that ended in Nov. 2023 was 0.00.

NDatalyze Debt-to-Revenue Historical Data

The historical data trend for NDatalyze's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NDatalyze Debt-to-Revenue Chart

NDatalyze Annual Data

Trend

Feb19

Feb20

Feb21

Feb22

Feb23

Debt-to-Revenue

NDatalyze Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Debt-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of NDatalyze's Debt-to-Revenue

For the Health Information Services subindustry, NDatalyze's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NDatalyze's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NDatalyze's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where NDatalyze's Debt-to-Revenue falls into.

NDatalyze Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

NDatalyze's Debt-to-Revenue for the fiscal year that ended in Feb. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	0.171
	=	0.00

NDatalyze's annualized Debt-to-Revenue for the quarter that ended in Nov. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	0.152
	=	0.00

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Nov. 2023) Revenue data.

NDatalyze Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of NDatalyze's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

NDatalyze (XCNQ:NDAT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NDatalyze Corp (XCNQ:NDAT) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

NDATF:USA

Address

707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6

Website

https://www.ndatalyze.com

NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.

NDatalyze (XCNQ:NDAT) Headlines

No Headlines